Evidence map›Paper›PMID 37321567›Full record

ArticleACS infectious diseases2023

Dihydroartemisinin Disrupts Zinc Homeostasis in

Hiroko Asahi, Mamoru Niikura, Shin-Ichi Inoue, Fujiro Sendo, Fumie Kobayashi, Akira Wada

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Hiroko AsahiLaboratory for Nonnatural Amino Acid Technology, RIKEN Center for Biosystems Dynamics Research, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan.
Mamoru NiikuraDivision of Tropical Diseases and Parasitology, Department of Infectious Diseases, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan.
Shin-Ichi InoueDivision of Immunology, Department of Molecular Microbiology and Immunology, Graduate School of Biomedical Sciences, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, Nagasaki 852-8523, Japan.
Fujiro SendoKojunosato, Geriatric Health Service Facilities, 8-1 Azahonmaru, Oazamizonobe, Kahoku-cho, Yamagata 999-3522, Japan.
Fumie KobayashiDepartment of Environmental Science, School of Life and Environmental Science, Azabu University, 1-17-71 Fuchinobe, Chuo-ku, Sagamihara, Kanagawa 252-5201, Japan.
Akira WadaLaboratory for Nonnatural Amino Acid Technology, RIKEN Center for Biosystems Dynamics Research, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan.ORCID 0000-0003-3570-9100
RIKEN Center for Biosystems Dynamics Research · JPAzabu University · JPKyorin University · JPNagasaki University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artemisinins have been used as first-line drugs worldwide to treat malaria caused by

Indexed as

AntimalarialsArtemisininsFolic Acid AntagonistsMalariaMalaria, FalciparumParasitesAnimalsGlutathioneHomeostasisHumansPlasmodium falciparumAntimalarialsArtemisininsartenimolFolic Acid AntagonistsGlutathionedihydroartemisininPlasmodium falciparumzinc depletionzinc homeostasis

Identifiers

PMID37321567
PMCPMC10353546
OpenAlexW4380728275

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.